Therefore, only ARHGEF26 exhibited consistent results across both the training and validation datasets, demonstrating a significant downregulation of ARHGEF26 in DKD renal glomerular tissues compared with that seen in control samples. This evidence concerns the gene ARHGEF26 and diabetic kidney disease.